OtoNexus Medical Technologies

OtoNexus Medical Technologies commercializes a patented medical device designed to diagnose middle ear infections in children and adults. It will allow clinicians to accurately identify viral vs. bacterial infection and determine whether an antibiotic is appropriate. The device applies a well-known medical technology, ultrasound, in a completely novel way to achieve a key advance in the detection of otitis media. One-use-per-patient tips create a recurring revenue stream. The device will provide data in seconds and will be easy to use by physicians or non-physician personnel (NPs, PAs).

OtoNexus Medical Technologies headquartered in United States, North America, operates in the Health Care, Medical, Medical Device, Health Diagnostics sector. The company focuses on Health Care and has secured $3.1B in funding across 160 round(s). With a team of 1-10 employees, OtoNexus Medical Technologies is actively contributing to advancements in Health Care. Their latest funding round, Convertible Note - OtoNexus Medical Technologies, raised $2.2M. Discover more about their projects, partnerships, and impact on our platform.